1885-642X
1885-642X
S1885-642X2019000400005
10.18549/pharmpract.2019.4.1588
United States
United States
United States
United States
United States
United States
United States
00
12
2019
00
12
2019
17
4
[
2016
164
11
11
740-51
]
[
American Diabetes Association
2019
42
Supplement 1
Supplement 1
S1-S187
]
[
2019
25
1
1
69-100
]
[
2011
54
1
1
10-8
]
[
2016
18
3
3
203-16
]
[
2006
91
11
11
4612-9
]
[
2014
63
1
1
9-19
]
[
2015
17
11
11
1065-74
]
[
2012
29
11
11
e417-24
]
[
2012
69
12
12
1044-8
]
[
2012
18
1
1
e10-3
]
[
2017
19
2
2
200-7
]
[
Centers for Disease Control and Prevention
2017
]
[
Amylin Pharmaceuticals Inc
2012
]
[
GlaxoSmithKline LLC
2014
]